Combined CYP1A1/GSTM1 at-risk genotypes are overrepresented in squamous cell lung carcinoma patients but underrepresented in elderly tumor-free subjects

Journal of Cancer Research and Clinical Oncology

Volumn 132, Issue 5, 2006, Pages 327-331

  Belogubova, Evgeniya V ^a   Ulibina, Yulia M ^a   Suvorova, Irina K ^a   Kuligina, Ekatherina Sh ^a   Karpova, Maria B ^a   Shutkin, Vladimir A ^b   Koloskov, Andrey V ^c   Kuchinskiy, Alexandr P ^d   Togo, Alexandr V ^a   Hanson, Kaido P ^a   Hirvonen, Ari ^e   Imyanitov, Evgeny N ^a  

^a N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

^b Moldovian Institute of Oncology   (Moldova)

^c City Hospital 26   (Russian Federation)

^d City Hospital 2   (Russian Federation)

^e FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

Author keywords

CYP1A1; Elderly; GSTM1; Lung cancer; Predisposition

Indexed keywords

CYTOCHROME P450 1A1; GLUTATHIONE TRANSFERASE M1;

AGED; ALLELE; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DONOR; ENZYME DEFICIENCY; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HUMAN; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; PREVALENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SENESCENCE; SMOKING; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CYTOCHROME P-450 CYP1A1; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; RISK FACTORS;

EID: 33644518400     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-005-0071-7     Document Type: Article

References (16)

1. Belogubova EV, Togo AV, Karpova MB, Kuligina ESh, Buslova KG, Ulibina JM, Lemehov VG, Romanenko SM, Shutkin VA, Hanson KP, Hirvonen A, Imyanitov EN (2004) A novel approach for assessment of cancer predisposing roles of GSTM1 and GSTT1 genes: use of putatively cancer resistant elderly tumor-free smokers as the referents Lung Cancer 43:259-266
2. Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrov K (2000) Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers Cancer Epidemiol Biomarkers Prev 9:3-28
3. Fryer AA, Jones PW (1999) Interactions between detoxifying enzyme polymorphisms and susceptibility to cancer IARC Sci Publ 148:303-322
4. Garte S, Crosti F (1999) A nomenclature system for metabolic gene polymorphisms IARC Sci Publ 148:5-12
5. Hayashi S, Watanabe J, Nakachi K, Kawajiri K (1991) Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene J Biochem (Tokyo) 110:407-411
6. Hayashi S, Watanabe J, Kawajiri K., (1992) High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IA1 and Mu-class glutathione S-transferase genes Jpn J Cancer Res 83:866-870
7. Hecht SS (1997) Tobacco and cancer: approaches using carcinogen biomarkers and chemoprevention Ann NY Acad Sci 833:91-111
8. Hirvonen A (2004) Genetic susceptibility to PAH-induced carcinogenesis. In: Luch A (ed) The carcinogenic effects of polycyclic aromatic hydrocarbons. Imperial College Press, London, 353-377
9. Imyanitov EN, Togo AV, Hanson KP (2004) Searching for cancer-associated gene polymorphisms: promises and obstacles Cancer Lett 204:3-14
10. Imyanitov EN, Kuligina ESh, Belogubova EV, Togo AV, Hanson KP (2005) Mechanisms of lung cancer Drug Discov Today Dis Mech 2: 213-223
11. Kihara M, Kihara M, Noda K (1995) Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population Carcinogenesis 16:2331-2336
12. Kiyohara C, Otsu A, Shirakawa T, Fukuda S, Hopkin JM (2002) Genetic polymorphisms and lung cancer susceptibility: a review Lung Cancer 37:241-256
13. Le Marchand L, Sivaraman L, Pierce L, Seifried A, Lum A, Wilkens LR, Lau AF (1998) Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens Cancer Res 58:4858-4863
14. Nakachi K, Imai K, Hayashi S, Kawajiri K (1993) Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population Cancer Res 53:2994-2999
15. Vineis P, Veglia F, Benhamou S, Butkiewicz D, Cascorbi I, Clapper ML, Dolzan V, Haugen A, Hirvonen A, Ingelman-Sundberg M, Kihara M, Kiyohara C, Kremers P, Le Marchand L, Ohshima S, Pastorelli R, Rannug A, Romkes M, Schoket B, Shields P, Strange RC, Stucker I, Sugimura H, Garte S, Gaspari L, Taioli E (2003) CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls. Int J Cancer 104:650-657
16. Vineis P, Veglia F, Anttila S, Benhamou S, Clapper ML, Dolzan V, Ryberg D, Hirvonen A, Kremers P, Le Marchand L, Pastorelli R, Rannug A, Romkes M, Schoket B, Strange RC, Garte S, Taioli E (2004) CYP1A1, GSTM1 and GSTT1 polymorphisms and lung cancer: a pooled analysis of gene-gene interactions Biomarkers 9:298-305